PFE
Pfizer Inc.
- Depreciation and amortization, 2025
- $6.6B
- YoY, 2025
- −6.0%
- 5-year CAGR
- +7.1%
- 10-year CAGR
- +2.5%
Depreciation and amortization
Depreciation and amortization by fiscal year
| Period | D&A | YoY |
|---|---|---|
| 2025 | $6.6B | −6.0% |
| 2024 | $7.0B | +11.5% |
| 2023 | $6.3B | +24.2% |
| 2022 | $5.1B | −2.4% |
| 2021 | $5.2B | +10.9% |
| 2020 | $4.7B | −18.7% |
| 2019 | $5.8B | −9.9% |
| 2018 | $6.4B | +1.8% |
| 2017 | $6.3B | +8.9% |
| 2016 | $5.8B | +11.6% |
| 2015 | $5.2B | −6.9% |
| 2014 | $5.5B | −12.2% |
| 2013 | $6.3B | −14.7% |
| 2012 | $7.4B | −15.0% |
| 2011 | $8.7B | +3.6% |
| 2010 | $8.4B | +76.6% |
| 2009 | $4.8B | −6.5% |
| 2008 | $5.1B | −2.1% |
| 2007 | $5.2B | — |